Fireside Discussions on NGS-Based Biosafety - A Gamechanger
Marie-Ange Kouassi February 8, 2022
World Cancer Day at Genedata
Genedata February 4, 2022
Facilitating Knowledge Exchange on NGS-Based Biosafety Testing
Marie-Ange Kouassi December 9, 2021
Going Beyond a Biomarker-Driven Strategy
Justyna Lisowska November 30, 2021
Screener User Community Comes Together
Ada Yee October 13, 2021
Leveraging Data on the Journey to Successful Cell Therapy
Justyna Lisowska & Marie-Ange Kouassi September 29, 2021
Interview: Bispecific Development at Amgen
Ada Yee September 1, 2021
The Promises and Challenges of Cell Therapies
Marie-Ange Kouassi August 25, 2021
Artificial Intelligence, Mass Spec, and COVID-19: Best of SLAS Europe
Ada Yee July 1, 2021
Knowledge Exchange on NGS-Based Cell Line Development
Marie-Ange Kouassi May 28, 2021
ASGCT Highlights: Advancements in Cell and Gene Therapy
Cristal Reyna Thompson May 27, 2021
Leveraging Technology for Integrative Approaches in IMIDs
Justyna Lisowska & Marie-Ange Kouassi May 5, 2021
Four Big Takeaways from the IO360° Conference
Cristal Reyna Thompson March 30, 2021
Endotyping: The Path to Precision Medicine for IMIDs
Marie-Ange Kouassi March 22, 2021
Our Team’s Favorite SLAS2021 Talks
Ada Yee February 23, 2021
Precision Medicine in IMIDs - Path to Improved Healthcare Outcomes
Justyna Lisowska February 9, 2021
New Trends in Clinical Trial Design & The Role of Bioinformatics Tools
Lakshmi Santhosh Maithel January 13, 2021
Searching for COVID-19 Treatments with HCS
Ada Yee July 28, 2020
Deep Learning-Based HCS Image Analysis—Our Paper is Out!
Stephan Steigele May 22, 2020
Lab of the Future Congress: My Top 3 Takeaways
Kevin Teburi November 19, 2019
How Cell Line Variability Impacts Screening
Ada Yee December 28, 2018
High Content Screening for Drug Repurposing: A New Resource
Ada Yee December 14, 2018
Genedata Screener Paper Highlights 2018
Genedata December 11, 2018
2018 Nobel Prizes - The Year of the Antibody
Genedata October 4, 2018
